A Study to Evaluate the Relative Bioavailability of Two Formulations of BIIB104 and Assess the Effect of Food on the Pharmacokinetics of BIIB104 Following Administration of a Single, Fixed, Oral Dose of BIIB104 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions

Healthy Volunteers

Interventions

DRUG

BIIB104 Reference Formulation

Administered as specified in the treatment arm

DRUG

BIIB104 Test Formulation

Administered as specified in the treatment arm

Trial Locations (1)

QPS MRA, Miami